Canal, C. E., Morgan, D., Felsing, D., Kondabolu, K., Rowland, N. E., Robertson, K. L., . . . Booth, R. G. (2014). A Novel Aminotetralin-Type Serotonin (5-HT) (2C) Receptor-Specific Agonist and 5-HT(2A) Competitive Antagonist/5-HT(2B) Inverse Agonist with Preclinical Efficacy for Psychoses. The American Society for Pharmacology and Experimental Therapeutics.

Canal, Clinton E., Drake Morgan, Daniel Felsing, Krishnakanth Kondabolu, Neil E. Rowland, Kimberly L. Robertson, Rajeev Sakhuja, and Raymond G. Booth. A Novel Aminotetralin-Type Serotonin (5-HT) (2C) Receptor-Specific Agonist and 5-HT(2A) Competitive Antagonist/5-HT(2B) Inverse Agonist With Preclinical Efficacy for Psychoses. The American Society for Pharmacology and Experimental Therapeutics, 2014.

Canal, Clinton E., et al. A Novel Aminotetralin-Type Serotonin (5-HT) (2C) Receptor-Specific Agonist and 5-HT(2A) Competitive Antagonist/5-HT(2B) Inverse Agonist With Preclinical Efficacy for Psychoses. The American Society for Pharmacology and Experimental Therapeutics, 2014.